Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?

Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?

Bibliografische gegevens
Hoofdauteur:	Glasziou, P
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2009

Gelijkaardige items

Pharmacopoeia boosts the fight against substandard drugs

The International pharmacopoeia /
door: World Health Organization
Gepubliceerd in: (2006)

British Pharmacopoeia 2015
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2014)

British Pharmacopoeia 2019
door: Stationery Office (Great Britain)
Gepubliceerd in: (2018)

British Pharmacopoeia 2012
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2011)

British pharmacopoeia 2011
door: Medicines and Healthcare Products Regulatory Agency
Gepubliceerd in: (2010)

British pharmacopoeia 2014
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2013)

British pharmacopoeia 2013
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2012)

British Pharmacopoeia 2016
door: Stationery Office (Great Britain)
Gepubliceerd in: (2015)

British Pharmacopoeia 2015
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2014)

British Pharmacopoeia 2017
door: Stationery Office (Great Britain)
Gepubliceerd in: (2016)

British pharmacopoeia 2018
door: Stationery Office (Great Britain)
Gepubliceerd in: (2017)

British pharmacopoeia 2011
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2010)

British Pharmacopoeia 2008/
door: Medicines and Healthcare Products Regulatory Agency
Gepubliceerd in: (2007)

British Pharmacopoeia 1993
Gepubliceerd in: (1993)

Lovewizard and God's pharmacopoeia
door: Carlos Lozano Quijada
Gepubliceerd in: (2012-06-01)

The International Pharmacopoeia: Focus, Processes, Response to COVID-19 and Collaboration with other Pharmacopoeias
door: H. Schmidt, et al.
Gepubliceerd in: (2023-06-01)

Comparison of the State Pharmacopoeia, XIII edition and the European Pharmacopoeia requirements for human plasma products
door: A. V. Karyakin, et al.
Gepubliceerd in: (2018-02-01)

Single botanical drugs in the Ayurvedic Pharmacopoeia of India—A quantitative ethnobotanical analysis
door: Ruyu Yao, et al.
Gepubliceerd in: (2023-05-01)

British Pharmacopoeia 2012 [electronic resource]
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2011)

British pharmacopoeia 2014 [electronic resource]
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2013)

British pharmacopoeia 2013 [electronic resource]
door: Medicines and Healthcare Products Regulatory Agency, et al.
Gepubliceerd in: (2012)

American herbal pharmacopoeia : botanical pharmacognosy /
door: Upton, Roy
Gepubliceerd in: (2011)

British Pharmacopoeia 1993 Addendum 1995
Gepubliceerd in: (1995)

“Antidotarium ” of Nicholas of Salerno : the history of the pharmacopoeia
door: F. D. Voronov, et al.
Gepubliceerd in: (2017-05-01)

The state pharmacopoeia in the system of higher education
door: I. I. Krasnyuk, et al.
Gepubliceerd in: (2018-02-01)

The history of development of Pharmacopoeia standards quality biological drugs and methods of tests in Russia
door: T. M. Kargina, et al.
Gepubliceerd in: (2018-02-01)

REGULATION OF DRUGS PRODUCTION IN RUSSIA XVI AND XVII CENTURIES: VINEYARD, PHARMACOPOEIAS, LECHEBNIK
door: Y. I. Zelikson
Gepubliceerd in: (2019-01-01)

Military pharmacopoeias at the turn of the 19th century
door: Maria Turos
Gepubliceerd in: (2019-12-01)

Pharmaceutical Substances. Requirements of the State Pharmacopoeia for Their Standardization
door: E. I. Sakanyan, et al.
Gepubliceerd in: (2020-05-01)

Scientific aspects of the development of the State Pharmacopoeia of Ukraine
door: A. I. Gryzodub
Gepubliceerd in: (2018-02-01)

Russian military pharmacopoeias in the military health system
door: Yu. V. Miroshnichenko, et al.
Gepubliceerd in: (2018-02-01)

Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia
door: Gaurav Pratap Singh Jadaun, et al.
Gepubliceerd in: (2023-12-01)

Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
door: Kelly L. Johnston, et al.
Gepubliceerd in: (2014-12-01)

The Indian Pharmacopoeia Commission: Challenge, Compliance of Pharmaceutical Industries
door: Ritu Tiwari, et al.
Gepubliceerd in: (2024-12-01)

PHARMACEUTICAL LEGISLATION: EUROPEAN PHARMACOPOEIA AND FORMULARIUM SLOVENICUM WITH SUPPLEMENTS
door: Martina Cvelbar, et al.
Gepubliceerd in: (2003-01-01)

Comparison of the World Pharmacopoeias’ Requirements for the Quality of Cell Lines
door: M. A. Vodyakova, et al.
Gepubliceerd in: (2020-09-01)

The History of the Creation of the VII State Pharmacopoeia of the USSR (Review)
door: K. S. Guzev
Gepubliceerd in: (2021-05-01)

TABLETS. REGULATORY REQUIREMENTS OF THE STATE PHARMACOPOEIA XIII EDITION
door: N. V. Isaeva, et al.
Gepubliceerd in: (2019-01-01)

The European Pharmacopoeia: bringing pharmaceutical standard harmonisation to Europe
door: Susanne Keitel
Gepubliceerd in: (2018-02-01)